Drug
Obinutuzumab And Pixantrone
Obinutuzumab And Pixantrone: highest development phase Phase 2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Obinutuzumab and Pixantrone NCT02499003 | Phase 2 | Lymphoma, Non-Hodgkin |
Latest
No recent events.
Follow Obinutuzumab And Pixantrone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.